If you suffer from heart disease, hypertension, diabetes, or obesity, or if you treat patients with these conditions, CELP will bring the issues and concerns of the cardiovascular and endocrine communities to FDA to help everyone engage, educate and collaborate on these significant health issues. CELP was established as part of FDA's Office of Health and Constituent Affairs